Listed

Nephros Inc: Form 10-Q for the period ended Jun 30, 2020

Filed with the SEC on Aug 5, 2020 and accepted by EDGAR at Aug 5, 2020, 16:05 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-04-01 to 2020-06-30$1.6mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2020-01-01 to 2020-06-30$4.1mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2020-04-01 to 2020-06-30$682.0kus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2020-01-01 to 2020-06-30$1.7mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2020-04-01 to 2020-06-30$895.0kus-gaap:GrossProfit
Gross profit6 months2020-01-01 to 2020-06-30$2.4mus-gaap:GrossProfit
Research and development3 months2020-04-01 to 2020-06-30$836.0kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2020-01-01 to 2020-06-30$1.4mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2020-04-01 to 2020-06-30$1.6mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2020-01-01 to 2020-06-30$3.6mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2020-04-01 to 2020-06-30−$1.6mus-gaap:OperatingIncomeLoss
Operating income6 months2020-01-01 to 2020-06-30−$2.6mus-gaap:OperatingIncomeLoss
Interest expense3 months2020-04-01 to 2020-06-30$30.0kus-gaap:InterestExpense
Interest expense6 months2020-01-01 to 2020-06-30$73.0kus-gaap:InterestExpense
Net income3 months2020-04-01 to 2020-06-30−$1.7mus-gaap:NetIncomeLoss
Net income6 months2020-01-01 to 2020-06-30−$2.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-04-01 to 2020-06-30−$0.19us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2020-01-01 to 2020-06-30−$0.33us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2020-01-01 to 2020-06-30−$3.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2020-01-01 to 2020-06-30$226.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2020-06-30$7.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-06-30$13.1mus-gaap:AssetsCurrent
Total assetsAt period end2020-06-30$16.6mus-gaap:Assets
Current liabilitiesAt period end2020-06-30$2.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-06-30$4.4mus-gaap:Liabilities
Long-term debtAt period end2020-06-30$711.0kus-gaap:LongTermDebt
Shareholders' equityAt period end2020-06-30$9.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-20-014717. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.